Gut Microbiota Mediate Periampullary Cancer Through Extracellular Matrix Proteins: A Causal Relationship Study

Zeying Cheng1,2, Liqian Du1,2, Hongxia Zhang3

  • 1School of Pharmacy, Lanzhou University, Lanzhou, China.

IET Systems Biology
|July 22, 2025
PubMed

Insights

Gut microbes influence periampullary cancer risk, with nine taxa linked to its development. This research identifies potential therapeutic drugs and extracellular matrix proteins involved in this rare digestive cancer.

Area of Science:

  • Gastroenterology
  • Oncology
  • Microbiology
  • Genetics

Background:

  • Gut microbiota dysbiosis is increasingly implicated in digestive system cancers.
  • Periampullary cancer is a rare malignancy with limited therapeutic options.
  • Understanding the gut microbiome's role is crucial for novel treatment strategies.

Purpose of the Study:

  • To investigate the association between gut microbial composition and periampullary cancer risk.
  • To identify potential therapeutic targets and drugs for periampullary cancer.

Main Methods:

  • Two-sample Mendelian randomization (MR) analysis using genome-wide association study (GWAS) data for gut microbial taxa and periampullary cancer.
  • Multivariable MR analysis incorporating differentially expressed extracellular matrix proteins.
  • Drug screening using the Connectivity Map.

Main Results:

  • Nine gut microbial taxa (Tyzzerella, Alloprevotella, Holdemania, LachnospiraceaeUCG010, Terrisporobacter, Alistipes, Rikenellaceae, Anaerofilum, Dialister) were significantly associated with periampullary cancer risk.
  • Extracellular matrix proteins, including Collagen alpha-1(I) chain, Laminin, Fibronectin, and Mucin, were identified as potential mediators.
  • 27 candidate drugs were identified for potential periampullary cancer therapy.

Conclusions:

  • Specific gut microbial taxa are associated with periampullary cancer risk.
  • Extracellular matrix proteins may mediate the link between gut microbiota and periampullary cancer.
  • This study provides a foundation for developing targeted therapies and diagnostic tools for periampullary cancer.